Found: 9
Select item for more details and to access through your institution.
Super-resolution microscopy reveals ultra-low CD19 expression on myeloma cells that triggers elimination by CD19 CAR-T.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-10948-w
- By:
- Publication type:
- Article
Characterization and Optimization of the Tumor Microenvironment in Patient-Derived Organotypic Slices and Organoid Models of Glioblastoma.
- Published in:
- Cancers, 2023, v. 15, n. 10, p. 2698, doi. 10.3390/cancers15102698
- By:
- Publication type:
- Article
Association between acquired resistance to PLX4032 (vemurafenib) and ATP-binding cassette transporter expression.
- Published in:
- BMC Research Notes, 2014, v. 7, p. 1, doi. 10.1186/1756-0500-7-710
- By:
- Publication type:
- Article
The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 499, p. 1, doi. 10.1126/scitranslmed.aau5907
- By:
- Publication type:
- Article
Super-resolution microscopy reveals ultra-low expression of CD19 on myeloma cells that triggers elimination by CAR-T cells.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e166, doi. 10.1016/j.clml.2019.09.277
- By:
- Publication type:
- Article
Karanjin interferes with ABCB1, ABCC1, and ABCG2.
- Published in:
- Journal of Pharmacy & Pharmaceutical Sciences, 2014, v. 17, n. 1, p. 92, doi. 10.18433/j3bw2s
- By:
- Publication type:
- Article
Differential effects of the oncogenic BRAF inhibitor PLX4032 (vemurafenib) and its progenitor PLX4720 on ABCB1 function.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Differential Effects of the Oncogenic BRAF Inhibitor PLX4032 (Vemurafenib) and its Progenitor PLX4720 on ABCB1 Function.
- Published in:
- Journal of Pharmacy & Pharmaceutical Sciences, 2014, v. 17, n. 1, p. 154, doi. 10.18433/j3tw24
- By:
- Publication type:
- Article
CAR T cells targeting Aspergillus fumigatus are effective at treating invasive pulmonary aspergillosis in preclinical models.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 664, p. 1, doi. 10.1126/scitranslmed.abh1209
- By:
- Publication type:
- Article